Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria

Kidney International Supplements

Volumn 3, Issue 2, 2013, Pages 195-201

  Ulasi, Ifeoma I ^a,b   Ijoma, Chinwuba K ^a   Onodugo, Obinna D ^a   Arodiwe, Ejikeme B ^a   Ifebunandu, Ngozi A ^b   Okoye, Julius U ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b FEDERAL TEACHING HOSPITAL   (Nigeria)

Author keywords

chronic kidney disease; Nigeria; prevalence; prevention; risk factors

Indexed keywords

EID: 84907540597     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2013.13     Document Type: Article

References (40)

1. Levey, A.S., Atkins, R., Coresh, J., et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72 (2007), 247–259.
2. Zhang, Q.-L., Rothenbacher, D., Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health, 8, 2008, 117.
3. Ijoma, C.K., Ulasi, I.I., Ijoma, U.N., et al. High prevalence of anemia in predialysis patients in Enugu, Nigeria. Nephrol Rev, 2, 2010, e14.
4. Afolabi, M.O., Abioye-Kuteyi, A.E., Arogundade, F.A., et al. Prevalence of chronic kidney disease in a Nigerian family practice population. SA Fam Pract 51 (2009), 132–137.
5. Ulasi, I.I., Ijoma, C.K., The enormity of chronic kidney disease in Nigeria: the situation in a Teaching Hospital in South-east Nigeria. J Trop Med, 2010:, 2010.
6. Akinsola, W., Odesanmi, W.O., Ogunniyi, J.O., et al. Diseases causing chronic renal failure in Nigerians—a prospective study of 100 cases. Afr J Med Med Sci 18 (1989), 131–135.
7. Luke, R.G., Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant 14 (1999), 2271–2278.
8. Hill, G.S., Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 17 (2008), 266–270.
9. Fogo, A., Breyer, J.A., Smith, M.C., et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in Africans: a report from the African American study of kidney disease(AASK) trial. AASK Pilot Study Investigators. Kidney Int 51 (1997), 244–252.
10. Ulasi, I.I., Ijoma, C.K., Onwubere, B.J.C., et al. High prevalence and low awareness of hypertension in a market population in Enugu, Nigeria. Int J Hypertens, 2011, 2011, 869675.
11. Kadiri, S., Arije, A., Salako, B.L., Traditional herbal preparations and acute renal failure in South West Nigeria. Trop Doct 29 (2000), 244–246.
12. Iseki, K., Tokashiki, K., Iseki, C., et al. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease. Clin Exp Nephrol. 12 (2008), 363–369.
13. Grossfeld, G.D., Wolf, J.S., Litwin, M.S., et al. Asymptomatic microscopic hematuria in adults: summary of the AUA Best Practice Policy Recommendations. Am Fam Physician 63 (2001), 1145–1154.
14. Obi, Y., Kimura, T., Nagasawa, Y., et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol 5 (2010), 1558–1565.
15. Huda, M.N., Alam, K.S., Harun-Ur-Rashid, Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population. Int J Nephrol, 2012, 2012, 267329.
16. Sumaili, E.K., Cohen, E.P., Screening of chronic kidney disease in sub-Saharan Africa. The Lancet, 367, 2010, 418.
17. Federal Ministry of Health, Non-Communicable Disease in Nigeria. Final Report of National Survey, Lagos, 1997, 1–118.
18. Erhun, W.O., Olayiwola, G., Agbani, E.O., et al. Prevalence of Hypertension in a University Community in South West Nigeria. Afr J Biomedl Res 8 (2005), 15–19.
19. American Diabetes Association, Nephropathy in diabetes. Diabetes Care 27 (2004), S79–S83.
20. Wang, A.Y., Cardiovascular risk in diabetic end-stage renal disease patients. JDiabetes 3 (2011), 119–131.
21. Sicree, R., Shaw, J., Zimmet, P., The global burden: diabetes and impaired glucose tolerance. IDF Diabetes Atlas. http://www.idf.org/sites/default/files/The_Global_Burden.pdf.
22. Ervin, R.B., Prevalence of Metabolic Syndrome Among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003–2006. J Altern Complement Med 4 (1998), 9–13.
23. Vanherweghem, L.J., Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium [Chinese herbs nephropathy]. J Altern Complement Med 4 (1998), 9–13.
24. Kadiri, S., Ogunlesi, A., Osinfade, K., et al. The causes and course of acute tubular necrosis in Nigerians. Afr Med Med Sci 21 (1992), 91–191.
25. Otieno, L.S., et al. Acute renal failure following the use of herbal remedies. East Afr Med J 68 (1919), 993–998.
26. Seedat, Y.K., Acute renal failure among Blacks and Indians in South Africa. S Afr Med J 54 (1978), 231–247.
27. Seedat, Y.K., Nathoo, B.C., Acute renal failure in Blacks and Indians in South Africa-comparison after 10 years. Nephron 64 (1993), 198–201.
28. Perazella, M.A., Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4 (2009), 1275–1283.
29. Su, T., Zhang, L., Li, X., et al. Regular use of nephrotoxic medication is an independent risk factor for chronic kidney disease-results from a Chinese population study. Nephrol Dial Transplant 26 (2011), 1916–1923.
30. Ulasi, I.I., Ijoma, C.K., Onodugo, O.D., A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Services Research, 10, 2010, 71.
31. WHO Steps Manual, Cardiovascular disease in developing countries (KHDC PROGRAM), 2005, International Society of Nephrology, Brussels.
32. International Society of Nephrology, Program for detection and management of chronic kidney disease, hypertension, diabetes and cardiovascular disease in developing countries (KHDC PROGRAM), 2005, International Society of Nephrology, Brussels, 17–19.
33. Davis, G.A., Chandler, M.H., Comparison of creatinine clearance estimation method in patients with trauma. Am J Health Syst Pharm 53 (1996), 1028–1032.
34. World Health Organization Consultation on Obesity, Obesity: Preventing and Managing the Global Epidemic, WHO Technical Report Series 894, 2000, World Health Organization, Geneva, Switzerland.
35. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (ATP III), Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002), 3143–3421.
36. World Health Organization. International Society of Hypertension Writing Group. 2003, World Health Organization/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003), 1983–1992.
37. A new equation to estimate glomerular filtration rate. Ann Intern 150 (2009), 604–612.
38. Levey, A.S., Stephen, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern 150 (2009), 604–612.
39. Worldwide prevalence of anemia, WHO Vitamin and Mineral Nutrition Information System, Ann Intern 150 (2009), 604–612.
40. 2006 Population and Housing Census of the Federal Republic of Nigeria, Enugu State Priority Tables April Vol XII (2010), 156–163.